Analysis of the disulfide bond arrangement of the HIV-1 envelope protein CON-S gp140 δcFI shows variability in the V1 and V2 regions

Journal of Proteome Research

Volumn 10, Issue 2, 2011, Pages 578-591

  Go, Eden P ^a   Zhang, Ying ^a   Menon, Sushma ^a   Desaire, Heather ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Disulfide; Envelope protein; HIV 1; LC ESI FTICR; Mass spectrometry

Indexed keywords

GLYCOPROTEIN GP 140; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE;

ARTICLE; DISULFIDE BOND; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN VARIANT;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, LIQUID; CONSENSUS SEQUENCE; DISULFIDES; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN, BOVINE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TRYPSIN;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79955403717     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100764a     Document Type: Article

References (43)

1. Fukuyama, Y.; Iwamoto, S.; Tanaka, K. J. Rapid sequencing and disulfide mapping of peptides containing disulfide bonds by using 1,5-diminonaphthalene as a reductive matrix. J. Mass. Spectrom. 2006, 41, 191-201. (Pubitemid 43260160)
2. Leonard, C. K.; Spellman, M. W.; Riddle, L.; Harris, R. J.; Thomas, J. N.; Gregory, T. J. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 1990, 265, 10373-10382.
3. Wefing, S.; Schnaible, V.; Hoffmann, D. SearchXLinks. A program for the identification of disulfide bonds in proteins from mass spectra. Anal. Chem. 2006, 78, 1235-1241. (Pubitemid 43271856)
4. Zhang, M.; Kaltashov, I. A. Mapping of protein disulfide bonds using negative ion fragmentation with a broadband precursor selection. Anal. Chem. 2006, 78, 4820-4829. (Pubitemid 44100615)
5. Nguyen, D. N.; Bechker, G. W.; Riggin, R. M. Protein mass spectrometry: application to analytical biotechnology. J. Chromatosr.. A. 1995, 705, 21-45.
6. Baneyx, F.; Mujacic, M. Recombinant protein folding and misfolding in Escherichia Coli. Nat. Biotechnol. 2004, 22, 1399-1408.
7. Gorman, J. J.; Wallis, T. P.; Pitt, J. J. Protein disulfide bond determination by mass spectrometry. Mass Spectrom. Rev. 2002, 21, 183-216.
8. Smith, D. L.; Zhou, Z. Strategies for locating disulfide bonds in proteins. Methods Enzymol. 1990, 193, 374-389.
9. Haniu, M.; Arakawa, T. Analysis of disulfide structures in proteins. Curr. Top. Pept. Protein Res. 1997, 2, 115-124.
10. Craik, D. J.; Daly, N. L. NMR as a tool for elucidating the structures of circular and knotted proteins. Mol. Biosyst. 2007, 3, 257-265. (Pubitemid 46456310)
11. Acharya, K. R.; Lloyd, M. D. The advantages and limitations of protein crystal structures. Trends Pharmacol. Sci. 2005, 26, 10-14. (Pubitemid 40052704)
12. Liu, H.; Hsu, J. Recent developments in structural proteomics for protein structure determination. Proteomics 2005, 5, 2056-2068. (Pubitemid 40770570)
13. Andrews, P. C. Selective isolation of disulfide-containing peptides from trypsin digests using strong cation exchange HPLC. Curr. Res. Protein Chem. 1990, 95-102.
14. Crimmins, D. L. Analysis of disulfide-linked homo- and heteropeptide dimmers with a strong cation-exchange sulfoethyl aspartamide column. Pept. Res. 1989, 2, 395-401.
15. Brown, J. R.; Kauffman, D. L.; Hartley, B. S. Primary structure of porcine pancreatic elastase; The N-terminus and disulfide bridges. Biochem. J. 1967, 103, 497-507.
16. Haniu, M.; Arakawa, T.; Bures, E. J.; Young, Y.; Hui, J. O.; Rohde, M. F.; Welcher, A. A.; Horan, T. Human leptin receptor. Determination of disulfide structure and N-glycosylation sites of the extracellular domain. J. Biol. Chem. 1998, 273, 28691-28699. (Pubitemid 28507555)
17. Irungu, J.; Go, E. P.; Dalpathado, D. S.; Desaire, H. Simplification of mass spectral analysis of acidic glycopeptides using GlycoPep ID. Anal. Chem. 2007, 79, 3065-3074. (Pubitemid 46640528)
18. Owusu-Apenten, R. K.; Chee, C.; Hwee, O. P. Evaluation of a sulphydryl-disulphide exchange index (SEI) for whey proteins - β-lactoglobulin and bovine serum albumin. Food Chem. 2003, 83, 541-545. (Pubitemid 37162806)
19. Liao, H.; Sutherland, L. L.; Xia, S.; Brock, M. E.; Scearce, R. M.; Vanleeuwen, S.; Alam, S. M.; McAdams, M.; Weaver, E. A.; Camacho, Z. T.; Ma, B.; Li, Y.; Decker, J. M.; Nabel, G. J.; Montefiori, D. C.; Hahn, B. H.; Korber, B. T.; Gao, F.; Haynes, B. F. Agroup M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. Virology 2006, 353, 268-282. (Pubitemid 44404137)
20. Kwong, P. D.; Wyatt, R.; Robinson, J.; Sweet, R. W.; Sodroski, J.; Hendrickson, W. A. Structure of an HIVgp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393, 648-659. (Pubitemid 28289647)
21. Wyatt, R.; Kwong, P. D.; Desjardins, E.; Sweet, R. W.; Robinson, J.; Hendrickson, W. A.; Sodroski, J. G. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 1998, 393, 705-711. (Pubitemid 28289663)
22. Zhou, T.; Xu, L.; Dey, B.; Hessell, A. J.; Van, R. D.; Xiang, S.-H.; Yang, X.; Zhang, M.-Y.; Zwick, M. B.; Arthos, J.; Burton, D. R.; Dimitrov, D. S.; Sodroski, J.; Wyatt, R.; Nabel, G. J.; Kwong, P. D. Structural definition of a conserved neutralization of epitope on HIV-1 gp120. Nature 2007, 445, 732-737. (Pubitemid 46279718)
23. Chen, B.; Vogan, E. M.; Gong, H.; Skehel, J. J.; Wiley, D. C.; Harrison, S. C. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005, 433, 834-841. (Pubitemid 40314887)
24. Flynn, N. M.; Forthal, D. N.; Harro, C. D.; Judson, F. N.; Mayer, K. H.; Para, M. F. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infect. Dis. 2005, 191, 654-665.
25. Gilbert, P. B.; Peterson, M. L.; Follmann, D.; Hudgens, M. G.; Francis, D. P.; Gurwith, M.; Heyward, W. L.; Jobes, D. V.; Popovic, V.; Self, S. G.; Sinangil, F.; Burke, D.; Berman, P. W. Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J. Infect. Dis. 2005, 191, 666-677. (Pubitemid 40271053)
26. Sharma, V. A.; Kan, E.; Sun, Y.; Lian, Y.; Cisto, J.; Frasca, V.; Hilt, S.; Stamatotos, L.; Donnelly, J. J.; Ulmer, J. B.; Barnett, S. W.; Srivastava, I. K. Structural characteristic correlate with immune responses induced by HIV envelope glycoprotein vaccines. Virology 2006, 352, 131-144. (Pubitemid 44142695)
27. Srivastava, I. K.; Stamatatos, L.; Legg, H.; Kan, E.; Fong, A.; Coates, S. R.; Leung, L.; Wininger, M.; Donnelly, J. J.; Ulmer, J. B.; Barnett, S. W. Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus. J. Virol. 2002, 76, 2835-2847. (Pubitemid 34184870)
28. Srivastava, I. K.; Stamatatos, L.; Kan, E.; Vajdy, M.; Lian, Y.; Hilt, S.; Martin, L.; Vita, C.; Zhu, P.; Roux, K. H.; Vojtech, L.; Montefiori, D. C.; Donnelly, J.; Ulmer, J. B.; Barnett, S. W. Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate. J. Virol. 2003, 77, 11244-11259. (Pubitemid 37204314)
29. Barnett, S. W.; Srivastava, I. K.; Ulmer, J. B.; Donnelly, J. J.; Rappuoli, R. Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and C. Microbes Infect. 2005, 7, 1386-1391. (Pubitemid 41655968)
30. Yuan, W.; Craig, S.; Yang, X.; Sodroski, J. Inter-subunit disulfide bonds in soluble HIV-1 envelope glycoprotein trimers. Virology 2005, 332, 369-383. (Pubitemid 40127256)
31. Center, R. J.; Earl, P. L.; Lebowitz, J.; Schuck, P.; Moss, B. The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts. J. Virol. 2000, 74, 4448-4455. (Pubitemid 30237869)
32. Center, R. J.; Leapman, R. D.; Lebowitz, J.; Arthur, L. O.; Earl, P. L.; Moss, B. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the viron surface. J. Virol. 2002, 76, 7863-7867. (Pubitemid 34761009)
33. Finzi, A.; Pacheco, B.; Zeng, X.; Kwon, Y. D.; Kwon, P. D.; Sodroski, J. Conformational characterization of aberrant disulfide-linked HIV-1 gp120 dimers secreted from overespressing cells. J. Virol. Methods. 2010. In Press.
34. Ihling, C.; Berger, K.; Hoefliger, M. M.; Fuehrer, D.; Beck-Sickinger, A. G.; Sinz, A. Nano-high-performance liquid chromatography in combination with nano-electrospray ionization Fourier transform ion-cyclotron resonance mass spectrometry for proteome analysis. Rapid Commun. Mass Spectrom. 2003, 17, 1240-1246. (Pubitemid 36750007)
35. Schnaible, V.; Wefing, S.; Buecker, A.; Wolf-Kuemmeth, S.; Hoffmann, D. Screening for disulfide bonds in proteins by MALDI insource decay and LIFT-TOF/TOF-MS. Anal. Chem. 2002, 74, 2386-2393.
36. Brown, J. R. Structure of serum albumin: disulfide bridges. Fed. Proc. 1974, 33, 1389-1389.
37. Moritz, R. L.; Hall, N. E.; Connolly, L. M.; Simpson, R. J. Determination of the disulfide structure and N-glycosylation sites of the extracellular domain of the human signal transducer gp130. J. Biol. Chem. 2001, 276, 8244-8253.
38. Go, E. P.; Irungu, J.; Zhang, Y.; Dalpathado, D. S.; Liao, H.-X.; Sutherland, L. L.; Alam, S. M.; Haynes, B. F.; Desaire, H. Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility. J. Proteome Res. 2008, 7, 1660-1674.
39. Jobes, D. V.; Daoust, M.; Nguyen, V.; Padua, A.; Michele, S.; Lock, M. D.; Chen, A.; Sinangil, F.; Berman, P. W. High incidence of unusual cysteine variants in gp120 envelope proteins from early HIV type 1 infections from a phase 3 vaccine efficacy trial. AIDS Res. Hum. Retroviruses 2006, 22, 1014-1021. (Pubitemid 46100687)
40. Mckeating, J. A.; Shotton, C.; Cordell, J.; Graham, S.; Balfe, P.; Sullivan, N.; Charles, M.; Page, M.; Bolmstedt, A. Characterization of neutralizing monoclonal antibodies to linear and conformation- dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120. J. Virol. 1993, 67, 4932-4944. (Pubitemid 23215975)
41. Pinter, A.; Honnen, W. J.; He, Y.; Gorny, M. K.; Zolla-Pazner, S.; Kayman, S. C. The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. J. Virol. 2004, 78, 5205-5215. (Pubitemid 38581472)
42. Walker, L. M.; Phogat, S. K.; Chan-Hui, P.-Y.; Wagner, D.; Phung, P.; Goss, J. L.; Wrin, T.; Simek, M. D.; Fling, S.; Mitcham, J. L.; Lehrman, J. K.; Priddy, F. H.; Olsen, O. A.; Frey, S. M.; Hammond, P. W.; Protocol G Principal Investigators, Kaminsky, S.; Zamb, T.; Moyle, M.; Koff, W. C.; Poignard, P.; Burton, D. R. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009, 326, 285-289.
43. Haynes, B. F.; Tsao, C. Y.; Bonisgnori, M. Personal communication.